Literature DB >> 10883717

Early detection of Alzheimer's disease using the Cambridge Cognitive Examination (CAMCOG).

B Schmand1, G Walstra, J Lindeboom, S Teunisse, C Jonker.   

Abstract

BACKGROUND: Dementia screening instruments, such as the Cambridge Cognitive Examination (CAMCOG), measure a variety of cognitive functions. However, memory impairment generally is the first sign of Alzheimer's disease (AD). It seems logical, therefore, to use only memory-related items for the early detection of AD. We divided the CAMCOG into a memory section and a non-memory section, and tested the hypothesis that the memory section predicts AD better than the non-memory section. We also provide normative data for both sections.
METHODS: Normal subjects (N = 169) and patients with incident AD (i.e. satisfying AD criteria between 1 and 3 years from baseline: N = 25) were participants in the Amsterdam Study of the Elderly (AMSTEL), a population-based longitudinal study on cognitive decline and dementia. Patients with prevalent AD (i.e. satisfying AD criteria at baseline: N = 155) were either recruited in a memory clinic or came from AMSTEL. Normal subjects were cognitively intact at baseline and remained so for at least 3 years. The CAMCOG was administered to all subjects. AD was diagnosed by DSM-III-R criteria.
RESULTS: Logistic regression analysis showed that the memory section was related to prevalent AD, whereas in multivariate analysis the non-memory section was not (after correction for the memory score and demographic characteristics). A similar analysis showed that the memory section predicted incident AD, as did a higher score on the non-memory section. The MMSE did not predict incident AD better than age alone.
CONCLUSION: For the early detection of AD it is best to use the memory and non-memory sections separately instead of the total CAMCOG score.

Entities:  

Mesh:

Year:  2000        PMID: 10883717     DOI: 10.1017/s0033291799002068

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  11 in total

Review 1.  Clinical assessment of social cognitive function in neurological disorders.

Authors:  Julie D Henry; William von Hippel; Pascal Molenberghs; Teresa Lee; Perminder S Sachdev
Journal:  Nat Rev Neurol       Date:  2015-12-16       Impact factor: 42.937

2.  Altered default mode network connectivity in Alzheimer's disease--a resting functional MRI and Bayesian network study.

Authors:  Xia Wu; Rui Li; Adam S Fleisher; Eric M Reiman; Xiaoting Guan; Yumei Zhang; Kewei Chen; Li Yao
Journal:  Hum Brain Mapp       Date:  2011-01-21       Impact factor: 5.038

3.  Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.

Authors:  M Combrinck; J Williams; M A De Berardinis; D Warden; M Puopolo; A D Smith; L Minghetti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06-08       Impact factor: 10.154

4.  Metalloproteinase's activity and oxidative stress in mild cognitive impairment and Alzheimer's disease.

Authors:  Sagrario Martín-Aragón; Paloma Bermejo-Bescós; Juana Benedí; Emanuela Felici; Pedro Gil; José Manuel Ribera; Angel Ma Villar
Journal:  Neurochem Res       Date:  2008-07-10       Impact factor: 3.996

5.  Adaptive cognitive testing in dementia.

Authors:  Hans Wouters; Aeilko H Zwinderman; Willem A van Gool; Ben Schmand; Robert Lindeboom
Journal:  Int J Methods Psychiatr Res       Date:  2009-06       Impact factor: 4.035

6.  Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI).

Authors:  Paloma Bermejo-Bescós; Sagrario Martín-Aragón; Karim Jiménez-Aliaga; Juana Benedí; Emanuela Felici; Pedro Gil; José Manuel Ribera; Angel María Villar
Journal:  Neurochem Res       Date:  2013-04-11       Impact factor: 3.996

Review 7.  Pharmacological interventions for cognitive decline in people with Down syndrome.

Authors:  Nuala Livingstone; Jennifer Hanratty; Rupert McShane; Geraldine Macdonald
Journal:  Cochrane Database Syst Rev       Date:  2015-10-29

8.  Do cerebral white matter lesions influence the rate of progression from mild cognitive impairment to dementia?

Authors:  Michael E Devine; J Andres Saez Fonseca; Zuzana Walker
Journal:  Int Psychogeriatr       Date:  2012-07-03       Impact factor: 3.878

9.  Dutch family physicians' awareness of cognitive impairment among the elderly.

Authors:  Pim van den Dungen; Eric P Moll van Charante; Peter M van de Ven; Gerbrand Foppes; Jos P C M van Campen; Harm W J van Marwijk; Henriëtte E van der Horst; Hein P J van Hout
Journal:  BMC Geriatr       Date:  2015-08-27       Impact factor: 3.921

10.  Case-finding of dementia in general practice and effects of subsequent collaborative care; design of a cluster RCT.

Authors:  Pim van den Dungen; Eric P Moll van Charante; Harm W J van Marwijk; Henriëtte E van der Horst; Peter M van de Ven; Hein P J van Hout
Journal:  BMC Public Health       Date:  2012-08-04       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.